Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Netherton syndrome (NS) is a severe genetic skin disease with constant atopic manifestations that is caused by mutations in the serine protease inhibitor Kazal-type 5 (SPINK5) gene, which encodes the protease inhibitor lymphoepithelial Kazal-type–related inhibitor (LEKTI). Lack of LEKTI causes stratum corneum detachment secondary to epidermal proteases hyperactivity. This skin barrier defect favors allergen absorption and is generally regarded as the underlying cause for atopy in NS. We show for the first time that the pro-Th2 cytokine thymic stromal lymphopoietin (TSLP), the thymus and activation-regulated chemokine, and the macrophage-derived chemokine are overexpressed in LEKTI-deficient epidermis. This is part of an original biological cascade in which unregulated kallikrein (KLK) 5 directly activates proteinase-activated receptor 2 and induces nuclear factor κB–mediated overexpression of TSLP, intercellular adhesion molecule 1, tumor necrosis factor α, and IL8. This proinflammatory and proallergic pathway is independent of the primary epithelial failure and is activated under basal conditions in NS keratinocytes. This cell-autonomous process is already established in the epidermis of Spink5−/− embryos, and the resulting proinflammatory microenvironment leads to eosinophilic and mast cell infiltration in a skin graft model in nude mice. Collectively, these data establish that uncontrolled KLK5 activity in NS epidermis can trigger atopic dermatitis (AD)–like lesions, independently of the environment and the adaptive immune system. They illustrate the crucial role of protease signaling in skin inflammation and point to new therapeutic targets for NS as well as candidate genes for AD and atopy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mutations or variants of genes such as SPINK5 favour the generation of allergen-independent, nonspecific inflammation, providing a pro-T helper 2 (TH2) micromilieu by virtue of keratinocyte-derived alarmins such as thymic stromal lymphopoietin (TSLP), IL-33 and IL-25 (refs52,64).”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The role of the innate immune system in the early phase of AD was demonstrated using animal models52–54 and is likely of clinical relevance in infancy55.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183
The cornified envelope: a model of cell death in the skin
Candi, E., Schmidt, R., & Melino, G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1619 · Cited by 1,776
Atopic dermatitis and the atopic march
Spergel, J. M., & Paller, A. S. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.033 · Cited by 1,229
Leung, D. Y., & Bieber, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12193-9 · Cited by 1,147
Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes
Rheinwald, J. G., & Green, H. (1977) · Nature · doi:10.1038/265421a0 · Cited by 1,066
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
Smith, F. J. D., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L. E., Zhao, Y., Liao, H., Evans, A. T., Goudie, D. R., Lewis-Jones, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1743 · Cited by 1,034 · cited 1×
“Recent genetic studies have shown that loss-of-function mutations in the gene encoding FILAGGRIN underlie ichthyosis vulgaris (6), a very common genetic disorder of keratinization.”
BackgroundMutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
Chavanas, S., Bodemer, C., Rochat, A., Hamel-Teillac, D., Ali, M., Irvine, A. D., Bonafé, J.-L., Wilkinson, J., Taïeb, A., Barrandon, Y., et al. (2000) · Nature Genetics · doi:10.1038/75977 · Cited by 856 · cited 1×
“We previously identified serine protease inhibitor Kazal-type 5 (SPINK5) as the defective gene in NS (26).”
BackgroundSelf-citationγ-Secretase-mediated proteolysis in cell-surface-receptor signalling
Fortini, M. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm910 · Cited by 824
Allakhverdi, Z., Comeau, M. R., Jessup, H. K., Yoon, B.-R. P., Brewer, A., Chartier, S., Paquette, N., Ziegler, S. F., Sarfati, M., & Delespesse, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062211 · Cited by 786
Cited by
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14891 · Cited by 1,181
The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch
Wilson, S. R., Thé, L., Batia, L. M., Beattie, K., Katibah, G. E., McClain, S. P., Pellegrino, M., Estandian, D. M., & Bautista, D. M. (2013) · Cell · doi:10.1016/j.cell.2013.08.057 · Cited by 987
Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
Ring, J., Alomar, A., Bieber, T., Deleuran, M., Fink‐Wagner, A., Gelmetti, C., Gieler, U., Lipozencic, J., Luger, T., Oranje, A. P., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04635.x · Cited by 683
“Barrier disruption leads to inflammation, and protease-antiprotease imbalance is a crucial intermediate step (Briot et al. 2009).”
BackgroundAtopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
Epithelial cell–derived cytokines: more than just signaling the alarm
Roan, F., Obata-Ninomiya, K., & Ziegler, S. F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124606 · Cited by 484
“TSLP overexpression has also been reported in Netherton syndrome, a genetic disease caused by mutations in SPINK5 that manifests in type 2 inflammation at multiple sites (16), and in some nonatopic pulmonary diseases such as chronic obstructive pulmonary disease (9).”
BackgroundGouin, O., L’Herondelle, K., Lebonvallet, N., Le Gall-Ianotto, C., Sakka, M., Buhé, V., Plée-Gautier, E., Carré, J.-L., Lefeuvre, L., Misery, L., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0395-5 · Cited by 425
Atopic dermatitis: A practice parameter update 2012
Schneider, L., Tilles, S., Lio, P., Boguniewicz, M., Beck, L., LeBovidge, J., Novak, N., Bernstein, D., Blessing-Moore, J., Khan, D., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.672 · Cited by 417
New Paradigms in Type 2 Immunity
Pulendran, B., & Artis, D. (2012) · Science · doi:10.1126/science.1221064 · Cited by 401
Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis
Thyssen, J. P., & Kezic, S. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.014 · Cited by 396
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases
Kubo, A., Nagao, K., & Amagai, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57416 · Cited by 378
Kabashima, K. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.02.001 · Cited by 361
“Thus far, at least four causes of xerosis have been considered: (1) decrease in skin ceramides [8], (ii) alterations of the stratum corneum pH [9], (iii) overexpression of the proteases, including kallikreins (KLKs) and chymases [10], and (iv) defect in Filaggrin (FLG) [11] (Fig.”
BackgroundProgramming dendritic cells to induce TH2 and tolerogenic responses
Pulendran, B., Tang, H., & Manicassamy, S. (2010) · Nature Immunology · doi:10.1038/ni.1894 · Cited by 355
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Mollanazar, N. K., Smith, P. K., & Yosipovitch, G. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8488-5 · Cited by 353
“Several studies have reported a correlation between PAR2 activity and TSLP expression in the skin of AD patients [110–112].”
BackgroundType 2 immunity: Expanding our view
Lloyd, C. M., & Snelgrove, R. J. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat1604 · Cited by 334
Choi, J. E., & Di Nardo, A. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0675-z · Cited by 331
“PAR-2 is involved in pruritus and various skin diseases such as atopic dermatitis [43, 44] while PAR-4 is involved in edema formation, leukocyte recruitment, and analgesia [45–49].”
New Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation
Leung, D. Y. M. (2013) · Allergology International · doi:10.2332/allergolint.13-rai-0564 · Cited by 331
Skin Barrier Disruption: A Requirement for Allergen Sensitization?
De Benedetto, A., Kubo, A., & Beck, L. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.435 · Cited by 317
“…TSLP and IL33 as well as TNFα, heat shock protein (Hsp) 90, Hsp70, and CXCL8 after tape stripping performed on healthy subjects or in Notch deficient mice who have a chronic skin barrier defect (Angelova-Fischer et al., 2010; Briot et al., 2009; Demehri et al., 2008; Dickel et al., 2010).”
BackgroundThe Biology of Thymic Stromal Lymphopoietin (TSLP)
Ziegler, S. F., Roan, F., Bell, B. D., Stoklasek, T. A., Kitajima, M., & Han, H. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-404717-4.00004-4 · Cited by 298
“…skin disease characterized by AD-like lesions as well as other allergic manifestations that result from mutations in the serine peptidase inhibitor Kazal-type 5 (SPINK5) gene, which encodes the serine protease inhibitor lymphoepithelial Kazaltype-related inhibitor (LEKTI) (Briot et al., 2009).”
InfluentialProtease-activated receptor 2 signaling in inflammation
Rothmeier, A. S., & Ruf, W. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0289-1 · Cited by 289
“While the progressive skin inflammation due to fragile dermis was not prevented by PAR2 deficiency , double deficient SPINK5 / PAR2− / − mice failed to induce TSLP [ 156 ] , identifying PAR2 signaling as a direct regulator of this signature cytokine in the pathology of Netherton syndrome .”
InfluentialMolecular Targets Underlying the Anticancer Effects of Quercetin: An Update
Khan, F., Niaz, K., Maqbool, F., Ismail Hassan, F., Abdollahi, M., Nagulapalli Venkata, K., Nabavi, S., & Bishayee, A. (2016) · Nutrients · doi:10.3390/nu8090529 · Cited by 282
“The TSLP signaling process is initiated through proteins, including 1L-7 chain of receptor, which has potential to enhance the B lymphocyte activation and dendritic cells [61].”
Backgroundvan Smeden, J., Janssens, M., Kaye, E. C. J., Caspers, P. J., Lavrijsen, A. P., Vreeken, R. J., & Bouwstra, J. A. (2014) · Experimental Dermatology · doi:10.1111/exd.12293 · Cited by 270
Lawrence, M. G., Lai, J., & Clements, J. A. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0034 · Cited by 265
Pathogenesis of atopic dermatitis
Peng, W., & Novak, N. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12495 · Cited by 258
Czarnowicki, T., Krueger, J. G., & Guttman-Yassky, E. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.004 · Cited by 260
The Itch–Scratch Cycle: A Neuroimmune Perspective
Mack, M. R., & Kim, B. S. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.10.001 · Cited by 255
“are mainly thought to be mediated by cleavage of protease-activated receptors (PARs) in the skin [52].”
TSLP Expression: Cellular Sources, Triggers, and Regulatory Mechanisms
Takai, T. (2012) · Allergology International · doi:10.2332/allergolint.11-rai-0395 · Cited by 255
Epithelial barrier repair and prevention of allergy
Goleva, E., Berdyshev, E., & Leung, D. Y. M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124608 · Cited by 251
“Transcriptome profiling revealed a KRT1-mediated gene expression signature resembling AD skin, with upregulation of S100A8, S100A9, and TSLP, compensatory increases in KRT5/14 filaments in basal epithelium, and increased KRT6/16 filaments in suprabasal epithelium (43).”
InfluentialType 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis
Beck, L. A., Cork, M. J., Amagai, M., De Benedetto, A., Kabashima, K., Hamilton, J. D., & Rossi, A. B. (2022) · JID Innovations · doi:10.1016/j.xjidi.2022.100131 · Cited by 245
“, 2006), and is linked to increased inflammation, itch, and epidermal barrier disruption (Briot et al., 2009; Wilson et al., 2013).”
BackgroundElias, P. M., & Wakefield, J. S. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.048 · Cited by 238
“This putative pH-induced increase in KLK activity generates the active 17-kDa forms of these cytokines, the first step in the cytokine cascade in patients with AD, which includes downstream production of several additional cytokines, growth factors, chemokines, and adhesion molecules,(32,90,91) including the thymic st…”
Unleashing the therapeutic potential of human kallikrein-related serine proteases
Prassas, I., Eissa, A., Poda, G., & Diamandis, E. P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4534 · Cited by 243
Genetic and epigenetic studies of atopic dermatitis
Bin, L., & Leung, D. Y. M. (2016) · Allergy, Asthma & Clinical Immunology · doi:10.1186/s13223-016-0158-5 · Cited by 242
“These changes all contribute to AD pathogenesis [102, 103].”
BackgroundFunctional Roles of Human Kallikrein-related Peptidases
Sotiropoulou, G., Pampalakis, G., & Diamandis, E. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.027946 · Cited by 240
Thymic stromal lymphopoietin and allergic disease
Ziegler, S. F. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.010 · Cited by 232
“In the setting of chronic high TSLP expression, skin inflammation also occurred in the absence of T cells,44 possibly because of the ongoing stimulation of innate immune cells by TSLP.”
BackgroundInfluentialLeyva-Castillo, J. M., Hener, P., Jiang, H., & Li, M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.239 · Cited by 231
“Whether it could be mediated via the proteinase-activated receptor 2 (Briot et al., 2009; Lee et al., 2010b) needs to be determined.”
BackgroundThe cutaneous innate immune response in patients with atopic dermatitis
Kuo, I.-H., Yoshida, T., De Benedetto, A., & Beck, L. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1563 · Cited by 231
Keratinocytes: innate immune cells in atopic dermatitis
Chieosilapatham, P., Kiatsurayanon, C., Umehara, Y., Trujillo-Paez, J. V., Peng, G., Yue, H., Nguyen, L. T. H., & Niyonsaba, F. (2021) · Clinical and Experimental Immunology · doi:10.1111/cei.13575 · Cited by 217
Netherton syndrome: skin inflammation and allergy by loss of protease inhibition
Hovnanian, A. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1558-1 · Cited by 211
“However, because these animals died rapidly and in the absence of an inducible Spink5 knock-out murine model, we developed Spink5 knock-out skin grafts onto nude mice to analyse the disease phenotype in adult skin (Briot et al. 2009).”
BackgroundMethodInfluentialSelf-citationAn IL-17–dominant immune profile is shared across the major orphan forms of ichthyosis
Paller, A. S., Renert-Yuval, Y., Suprun, M., Esaki, H., Oliva, M., Huynh, T. N., Ungar, B., Kunjravia, N., Friedland, R., Peng, X., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.019 · Cited by 204
“These model systems chiefly focus on abnormal barrier function and lipid homeostasis, with little attention paid to immune disturbances.(6,30,31) Human studies, largely limited to Netherton syndrome (NS) and the lamellar ichthyosis (LI) phenotype of autosomal recessive congenital ichthyosis (ARCI), have examined just…”
BackgroundResultSkin barrier defects in atopic dermatitis
Agrawal, R., & Woodfolk, J. A. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0433-9 · Cited by 201
The importance of TSLP in allergic disease and its role as a potential therapeutic target
Cianferoni, A., & Spergel, J. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.967684 · Cited by 198
“In SPINK5 knockout (SPINK5) mice, the absence of lymphoepithelial Kazal-type-related inhibitor results in unrestrained activity of the serine protease kallikrein 5, which directly activates PAR-2 and induces NF-kBmediated overexpression of TSLP without contribution from the adaptive immune system [69,75]”
BackgroundBell, B. D., Kitajima, M., Larson, R. P., Stoklasek, T. A., Dang, K., Sakamoto, K., Wagner, K.-U., Kaplan, D. H., Reizis, B., Hennighausen, L., et al. (2013) · Nature Immunology · doi:10.1038/ni.2541 · Cited by 193
Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine
Bieber, T. (2012) · Allergy · doi:10.1111/all.12049 · Cited by 190
“deficiency (42), it was shown that this deficiency induces a series of proinflammatory and proallergic pathways, including a high production of TSLP independent of the environment and the adaptive immune system.”
BackgroundRerknimitr, P., Otsuka, A., Nakashima, C., & Kabashima, K. (2017) · Inflammation and Regeneration · doi:10.1186/s41232-017-0044-7 · Cited by 187
“Moreover, by binding to the proteaseactivated receptor type 2 (PAR2) on keratinocytes, KLKs can induce thymic stromal lymphopoietin (TSLP) production that further promotes inflammation [39, 40].”
BackgroundCutaneous barrier dysfunction in allergic diseases
Leung, D. Y. M., Berdyshev, E., & Goleva, E. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.02.021 · Cited by 190
Vu, A. T., Baba, T., Chen, X., Le, T. A., Kinoshita, H., Xie, Y., Kamijo, S., Hiramatsu, K., Ikeda, S., Ogawa, H., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.002 · Cited by 186
Infant epidermal skin physiology: adaptation after birth: Skin physiology adaptation in infants
Fluhr, J. W., Darlenski, R., Lachmann, N., Baudouin, C., Msika, P., De Belilovsky, C., & Hachem, J.-P. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10659.x · Cited by 185
Veldhuis, N. A., Poole, D. P., Grace, M., McIntyre, P., & Bunnett, N. W. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009555 · Cited by 172
“A relationship between proteases, PAR2 signaling, and TLSP has been reported for models of dermatitis (Briot et al., 2009, 2010).”
BackgroundPattarini, L., Trichot, C., Bogiatzi, S., Grandclaudon, M., Meller, S., Keuylian, Z., Durand, M., Volpe, E., Madonna, S., Cavani, A., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20150402 · Cited by 170
“It has recently been shown that TSLP is highly expressed in a mouse model for NS and in the skin of NS patients (Briot et al., 2009).”
Self-citationLocal Protease Signaling Contributes to Neural Tube Closure in the Mouse Embryo
Camerer, E., Barker, A., Duong, D. N., Ganesan, R., Kataoka, H., Cornelissen, I., Darragh, M. R., Hussain, A., Zheng, Y.-W., Srinivasan, Y., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.11.014 · Cited by 169
“, 2002), and excessive Klk5 activity secondary to loss of Kazal-type related inhibitor (LektI; encoded by the Spink5 gene) has been suggested to drive stratum corneum detachment in Netherton syndrome in a PAR2-dependent manner (Briot et al., 2009).”
BackgroundThe Genetics and Epigenetics of Atopic Dermatitis—Filaggrin and Other Polymorphisms
Liang, Y., Chang, C., & Lu, Q. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8508-5 · Cited by 166
“Interestingly, a recent study found that prenatal tobacco smoke exposure may lead to TSLP DNA demethylation in human cord blood, which is positively associated with AD [11].”
BackgroundInfluentialNeutrophils promote CXCR3-dependent itch in the development of atopic dermatitis
Walsh, C. M., Hill, R. Z., Schwendinger-Schreck, J., Deguine, J., Brock, E. C., Kucirek, N., Rifi, Z., Wei, J., Gronert, K., Brem, R. B., et al. (2019) · eLife · doi:10.7554/elife.48448 · Cited by 166
Dumortier, A., Durham, A.-D., Di Piazza, M., Vauclair, S., Koch, U., Ferrand, G., Ferrero, I., Demehri, S., Song, L. L., Farr, A. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009258 · Cited by 164
“However, additional cell intrinsic mechanisms within skin epithelial cells have recently been shown to contribute to TSLP expression in the absence of barrier defects or microbial products [59].”
BackgroundTissue factor and cell signalling in cancer progression and thrombosis
RUF, W., DISSE, J., CARNEIRO‐LOBO, T. C., YOKOTA, N., & SCHAFFNER, F. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04318.x · Cited by 162
Doxycycline as an anti‐inflammatory agent: updates in dermatology
Henehan, M., Montuno, M. A., & Benedetto, A. D. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14345 · Cited by 167
Dynamic role of epithelium-derived cytokines in asthma
Bartemes, K. R., & Kita, H. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.03.001 · Cited by 154
“TSLP was also overexpressed in the skin of individuals with Netherton syndrome, a severe skin disease characterized by atopic dermatitis-like lesions that result from mutations in the serine peptidase inhibitor Kazal-type 5 (SPINK5) gene [64].”
The role of thymic stromal lymphopoietin (TSLP) in allergic disorders
Ziegler, S. F. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.10.020 · Cited by 154
Protease and Protease-Activated Receptor-2 Signaling in the Pathogenesis of Atopic Dermatitis
Lee, S. E., Jeong, S. K., & Lee, S. H. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2010.51.6.808 · Cited by 155
Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis
Kim, J. E., Kim, J., Cho, D., & Park, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081234 · Cited by 166
“In a LEKTI-knockout mouse model, increased kallikrein-5 stimulated proteinase-associated receptor-2 (PAR2), which activates nuclear factor κ B-induced overexpression of thymic stromal lymphopoietin (TSLP) and induces pruritus [95].”
BackgroundNatural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
Goettig, P., Magdolen, V., & Brandstetter, H. (2010) · Biochimie · doi:10.1016/j.biochi.2010.06.022 · Cited by 143
“In addition to the elevated degradation of corneodesmosomes in the stratum corneum, KLK5 causes atopic dermatitis-like lesions via PAR2-mediated thymic stromal lymphopoietin expression [215].”
BackgroundChoi, E. H. (2019) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2019.04.009 · Cited by 154
Barrier Dysfunction Caused by Environmental Proteases in the Pathogenesis of Allergic Diseases
Takai, T., & Ikeda, S. (2011) · Allergology International · doi:10.2332/allergolint.10-rai-0273 · Cited by 141
Kubo, A., Shiohama, A., Sasaki, T., Nakabayashi, K., Kawasaki, H., Atsugi, T., Sato, S., Shimizu, A., Mikami, S., Tanizaki, H., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.015 · Cited by 137
Simon, D., Radonjic-Hösli, S., Straumann, A., Yousefi, S., & Simon, H.-U. (2015) · Allergy · doi:10.1111/all.12570 · Cited by 138
“It has been demonstrated previously that a lack of LEKTI expression in keratinocytes results in increased activity of the protease kallikrein 5, thus directly activating proteinase-activated receptor (PAR)-2 which in turn triggers subsequent TSLP expression and Th2-type skin inflammation (42, 43).”
BackgroundMolecular targets of quercetin with anti-inflammatory properties in atopic dermatitis
Karuppagounder, V., Arumugam, S., Thandavarayan, R. A., Sreedhar, R., Giridharan, V. V., & Watanabe, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.011 · Cited by 135
Itch: A Paradigm of Neuroimmune Crosstalk
Wang, F., & Kim, B. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.008 · Cited by 129
Association between Stress and the HPA Axis in the Atopic Dermatitis
Lin, T.-K., Zhong, L., & Santiago, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102131 · Cited by 127
Bonnart, C., Deraison, C., Lacroix, M., Uchida, Y., Besson, C., Robin, A., Briot, A., Gonthier, M., Lamant, L., Dubus, P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41440 · Cited by 129
Self-citationMalik, K., He, H., Huynh, T. N., Tran, G., Mueller, K. A., Doytcheva, K., Renert‐Yuval, Y., Czarnowicki, T., Magidi, S., Chou, M. M., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.021 · Cited by 140
“Patients with NS carry serine protease inhibitor, Kazal-type 5 mutations, leading to unopposed KLK5– protease-activated receptor 2–TSLP activation and induction of TH2 and TNF-a, an identified gene target of KLK5–proteaseactivated receptor 2 signaling.(46,47,98) Contrary to patients with NS, which has been linked clas…”
TSLP, IL-33, and IL-25: Not just for allergy and helminth infection
Stanbery, A. G., Smita, S., von Moltke, J., Wojno, E. D. T., & Ziegler, S. F. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.07.003 · Cited by 151
Jang, H., Matsuda, A., Jung, K., Karasawa, K., Matsuda, K., Oida, K., Ishizaka, S., Ahn, G., Amagai, Y., Moon, C., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.363 · Cited by 134
Kanada, K. N., Nakatsuji, T., & Gallo, R. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.14 · Cited by 125
“KLK5 itself triggers a proinflammatory microenvironment independently of external stimuli by inducing cytokine overexpression and defective stratum corneum adhesion (Briot et al., 2009; Voegeli et al., 2009).”
BackgroundThe Varieties of Immunological Experience: Of Pathogens, Stress, and Dendritic Cells
Pulendran, B. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075049 · Cited by 121
Protease-activated receptors in health and disease
Peach, C. J., Edgington-Mitchell, L. E., Bunnett, N. W., & Schmidt, B. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00044.2021 · Cited by 116
Frateschi, S., Camerer, E., Crisante, G., Rieser, S., Membrez, M., Charles, R.-P., Beermann, F., Stehle, J.-C., Breiden, B., Sandhoff, K., et al. (2011) · Nature Communications · doi:10.1038/ncomms1162 · Cited by 115
Williams, M. R., Cau, L., Wang, Y., Kaul, D., Sanford, J. A., Zaramela, L. S., Khalil, S., Butcher, A. M., Zengler, K., Horswill, A. R., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.021 · Cited by 133
“The mouse Spink5 knockout is lethal shortly after birth because of a severely impaired epidermal skin barrier (Bonnart et al., 2010; Briot et al., 2009; Descargues et al., 2005).”
BackgroundSelf-citationSales, K. U., Masedunskas, A., Bey, A. L., Rasmussen, A. L., Weigert, R., List, K., Szabo, R., Overbeek, P. A., & Bugge, T. H. (2010) · Nature Genetics · doi:10.1038/ng.629 · Cited by 117
PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes
Zhao, J., Munanairi, A., Liu, X.-Y., Zhang, J., Hu, L., Hu, M., Bu, D., Liu, L., Xie, Z., Kim, B. S., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.01.012 · Cited by 115
Disease modification in inflammatory skin disorders: opportunities and challenges
Bieber, T. R. M. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00735-0 · Cited by 141
Briot, A., Lacroix, M., Robin, A., Steinhoff, M. S., Deraison, C., & Hovnanian, A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.233 · Cited by 111
“, 2006), leading to the induction of TSLP, ICAM1, and TNFa expression in human primary keratinocytes (Briot et al., 2009).”
BackgroundMethodInfluentialSelf-citationTransgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome
Furio, L., de Veer, S. J., Jaillet, M., Briot, A., Robin, A., Deraison, C., & Hovnanian, A. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131797 · Cited by 119
“Studies on Spink5/ skin have been limited to grafting experiments on WT mice and have shown enhanced expression of proinflammatory cytokines, such as Il1, Tnf, IL8, and Icam1 and proallergic mediators, such as Tslp, Ccl17 (Tarc), and Ccl22 (Mdc; Briot et al., 2009).”
BackgroundResultInfluentialSelf-citationTargeted treatment of pruritus: a look into the future
Tey, H. L., & Yosipovitch, G. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10217.x · Cited by 112
Proteases: common culprits in human skin disorders
de Veer, S. J., Furio, L., Harris, J. M., & Hovnanian, A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.005 · Cited by 119
Self-citationPerspectives on the etiology of chronic rhinosinusitis
Tan, B. K., Schleimer, R. P., & Kern, R. C. (2010) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e3283350053 · Cited by 105
“Furthermore, recent studies suggest that the absence of protease inhibitors like LEKT1 (see above) may increase TSLP production [35].”
BackgroundTherapeutic implications of a barrier-based pathogenesis of atopic dermatitis
Elias, P. M., & Wakefield, J. S. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8231-1 · Cited by 103
Moniaga, C. S., Jeong, S. K., Egawa, G., Nakajima, S., Hara‐Chikuma, M., Jeon, J. E., Lee, S. H., Hibino, T., Miyachi, Y., & Kabashima, K. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.039 · Cited by 105
Functions of thymic stromal lymphopoietin in immunity and disease
Zhang, Y., & Zhou, B. (2012) · Immunologic Research · doi:10.1007/s12026-012-8264-z · Cited by 101
“defects of the serine protease inhibitor Kazal-type 5 (SPINK5) in NS resulted in uncontrolled epidermal serine protease kallikrein 5 (KLK5) activity, which in turn activated proteinase-activated receptor 2 (PAR2) and induced nuclear factor NF-jB-mediated overexpression of TSLP [21, 22].”
The role of filaggrin in the atopic diathesis
O'Regan, G. M., & Irvine, A. D. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03522.x · Cited by 101
KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype
Kašpárek, P., Ileninova, Z., Zbodakova, O., Kanchev, I., Benada, O., Chalupský, K., Brattsand, M., Beck, I. M., & Sedláček, R. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006566 · Cited by 101
Fujii, M. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00088 · Cited by 119
Skin Barrier in Atopic Dermatitis
Schmuth, M., Eckmann, S., Moosbrugger‐Martinz, V., Ortner, D., Blunder, S., Trafoier, T., Gruber, R. W., & Elias, P. M. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.03.006 · Cited by 126
KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome
Furio, L., Pampalakis, G., Michael, I. P., Nagy, A., Sotiropoulou, G., & Hovnanian, A. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005389 · Cited by 103
“proteolytic processing of the cathelicidin precursor also contributes to skin inflammation through the release of antimicrobial and pro-inflammatory peptides [15,31,32].”
BackgroundResultInfluentialSelf-citationFortugno, P., Furio, L., Teson, M., Berretti, M., El Hachem, M., Zambruno, G., Hovnanian, A., & D'Alessio, M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds243 · Cited by 97
“As we have learnt from NS, unrestrained KLKs activity and epidermal barrier defects secondary to LEKTI deficiency induce the priming of a cutaneous allergic inflammation (22,23).”
BackgroundInfluentialSelf-citationIto, T., Liu, Y.-J., & Arima, K. (2012) · Allergology International · doi:10.2332/allergolint.11-rai-0376 · Cited by 106
Kim, Y.-J., Choi, M. J., Bak, D., Lee, B. C., Ko, E. J., Ahn, G. R., Ahn, S. W., Kim, M. J., Na, J., & Kim, B. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-30404-x · Cited by 99
Ghosh, D., Ding, L., Sivaprasad, U., Geh, E., Biagini Myers, J., Bernstein, J. A., Khurana Hershey, G. K., & Mersha, T. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144316 · Cited by 94
“Induction of AD-like lesions through PAR2-mediated thymic stromal lymphopoietin expression has been demonstrated in Netherton syndrome [58].”
BackgroundMolecular Biology of Atopic Dermatitis
Mu, Z., Zhao, Y. P., Liu, X., Chang, C. C.-C., & Zhang, J. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8415-1 · Cited by 113
Protease allergens as initiators–regulators of allergic inflammation
Soh, W. T., Zhang, J., Hollenberg, M. D., Vliagoftis, H., Rothenberg, M. E., Sokol, C. L., Robinson, C., & Jacquet, A. (2023) · Allergy · doi:10.1111/all.15678 · Cited by 96
Eissa, A., Amodeo, V., Smith, C. R., & Diamandis, E. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125310 · Cited by 92
The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond
Roan, F., Bell, B. D., Stoklasek, T. A., Kitajima, M., Han, H., & Ziegler, S. F. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211622 · Cited by 93
“without contribution of the adaptive immune system [47, 52].”
BackgroundInfluential
Metadata
- Authors
- Briot, A., Deraison, C., Lacroix, M., Bonnart, C., Robin, A., Besson, C., Dubus, P., & Hovnanian, A.
- Affiliations
- Université Toulouse III - Paul Sabatier (FR)
- Institut National de la Santé et de la Recherche Médicale, U563, Toulouse F-31300, France 1
- Université Bordeaux Segalen (FR)
- Corresponding author
- Hovnanian, Alain
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2009-05-04
- Volume
- 206
- Issue
- 5
- Pages
- 1135-1147
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2715042
- OpenAlex
- W2144344238
- Cited by
- 504
- References
- 71
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 22 · 2023: 18 · 2022: 32 · 2021: 24 · 2020: 30 · 2019: 37 · 2018: 22 · 2017: 31 · 2016: 40 · 2015: 30 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 42.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-MRAR-0009)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
- Keywords
- Netherton syndrome, kallikrein 5, SPINK5, LEKTI, atopic dermatitis, protease-activated receptor 2, thymic stromal lymphopoietin, keratinocytes, NF-κB signaling, Th2 cytokines, skin barrier dysfunction, eosinophilic dermatitis, mast cell infiltration, protease signaling, atopy
- MeSH terms
- Serine Peptidase Inhibitor Kazal-Type 5, Animals, Dermatitis, Atopic, Epidermis, Inflammation, Kallikreins, Mice, Nude, Skin, Serpins, Skin Transplantation, Mice, Knockout, Dermis, Mice, Keratin-14
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.